Plasmapheresis Withdrawn Phase 4 Trials for Mycophenolate mofetil (DB00688)

Also known as: Plasmaphoresis

IndicationStatusPhase
DBCOND0023694 (Plasmapheresis)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00203281Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis